Titlebook: Clinical Trials in Retinitis Pigmentosa Treatment; Jeffrey N. Weiss Book 2024 The Editor(s) (if applicable) and The Author(s), under exclu

POINT

Gian Paolo Jesi,Edoardo MollonaThis chapter contains a listing and summary of all the enrolling by invitation gene therapy studies for retinitis pigmentosa treatment. Countries with enrolling by invitation gene therapy studies include the United States, Canada, and India.

珍奇

https://doi.org/10.1007/978-3-319-18153-0This chapter contains a listing and summary of all the current active, not recruiting optogenetics studies for retinitis pigmentosa treatment. Countries with currently active optogenetics studies include the United States.

豪华

https://doi.org/10.1007/978-3-642-54432-3This chapter contains a listing and summary of all the completed studies for retinitis pigmentosa treatment. Countries with various other competed studies for retinitis pigmentosa treatment include the United States, China, Italy, and Turkey.

技术

Notes,This chapter contains notes from the author regarding Retinitis Pigmentosa and the relevant SCOTS I and II clinical trials.

municipality

唠叨

Active, Recruiting Stem Cell StudiesThis chapter contains a listing and summary of all the current active, recruiting studies for retinitis pigmentosa. Countries with current recruiting studies include the United States and Turkey, as well as the Latin American region.

无法解释

Not Yet Recruiting Stem Cell StudiesThis chapter contains a listing and summary of all the not yet recruiting stem cell studies for retinitis pigmentosa. Countries with not yet recruiting stem cell studies include Indonesia.

现实

Active, Not Recruiting Stem Cell StudiesThis chapter contains a listing and summary of all the current active, not recruiting stem cell studies for retinitis pigmentosa treatment. Countries with currently active studies include the United States and France.

集合

Enrolling by Invitation Stem Cell StudiesThis chapter contains a listing and summary of all the enrolling by invitation stem cell studies for retinitis pigmentosa treatment. Countries with enrolling by invitation stem cell studies include the United States and Indonesia.

迅速成长